ClinConnect ClinConnect Logo
Search / Trial NCT05250258

Telephone Peer Support to Prevent Depression Among Fathers

Launched by KAROLINSKA INSTITUTET · Feb 10, 2022

Trial Information

Current as of July 27, 2025

Not yet recruiting

Keywords

Telephone Peer Support Depression Fathers

ClinConnect Summary

This clinical trial, titled "Telephone Peer Support to Prevent Depression Among Fathers," is exploring whether support from other fathers over the phone can help new dads feel less stressed and depressed after their baby is born. The study involves 40 expectant fathers in Sweden who are experiencing some signs of depression shortly after their child's birth. These fathers will be divided into two groups: one group will receive phone support from trained volunteer fathers who have been through similar experiences, while the other group will receive standard parental support. Researchers will check in with the fathers four months later to see how they are doing.

To participate in this study, fathers need to be between 18 and 49 years old, have a baby that is less than two weeks old, and have a score of more than ten on a depression screening tool called the Edinburgh Postnatal Depression Scale. It's important to note that fathers who are currently taking medication for depression or other mental health issues will not be able to join. This study aims to find new ways to support fathers' mental health, which can ultimately lead to better outcomes for their children as well.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Aged 18 - 49 years old,
  • Less than two weeks postpartum
  • Scored more than ten on the -Edingburg postnatal depression scale (EPDS ) scale \<10 = indicate depression
  • Swedish or English speaking
  • Exclusion Criteria:
  • - Current use of anti-depressant or anti-psychotic medication

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Huddinge, Stockholms Län, Sweden

Huddinge, , Sweden

Patients applied

0 patients applied

Trial Officials

Ewa Andersson, Dr

Principal Investigator

Karolinska Institutet

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials